DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1BUPROPION HYDROCHLORIDE
02 1CARVEDILOL
03 1CIPROFLOXACIN
04 1CIPROFLOXACIN HYDROCHLORIDE
05 1GLYBURIDE
06 1HYDROCODONE BITARTRATE AND ACETAMINOPHEN
07 1METRONIDAZOLE
08 1NITROFURANTOIN
09 1PROPRANOLOL HYDROCHLORIDE
10 1TACROLIMUS
11 1ZIPRASIDONE HYDROCHLORIDE
01 140729
02 170035
03 170175
04 174388
05 276558
06 176649
07 177025
08 177565
09 1206651
10 1210497
01 11No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : ZIPRASIDONE HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77565
Country : US
Patented : No
Drug : BUPROPION HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 210497
Country : US
Patented : No
Drug : PROPRANOLOL HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 70175
Country : US
Patented : No
Drug : METRONIDAZOLE
Dosage Form : TABLET; ORAL
Application Number : 70035
Country : US
Patented : No
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Drug : HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Dosage Form : TABLET; ORAL
Application Number : 40729
Country : US
Patented : No
NITROFURANTOIN, MACROCRYSTALLINE
Drug : NITROFURANTOIN
Dosage Form : CAPSULE; ORAL
Application Number : 77025
Country : US
Patented : No
Drug : CIPROFLOXACIN HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 76558
Country : US
Patented : No
Drug : CIPROFLOXACIN
Dosage Form : TABLET; ORAL
Application Number : 76558
Country : US
Patented : No
Drug : GLYBURIDE
Dosage Form : TABLET; ORAL
Application Number : 74388
Country : US
Patented : No
Drug : TACROLIMUS
Dosage Form : CAPSULE; ORAL
Application Number : 206651
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
